A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
about
Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"Zellweger spectrum disorders: clinical overview and management approachBleeding in a patient taking Lorenzo's oil: evidence for a vascular defectTherapeutic developments in peroxisome biogenesis disorders.Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.Treatment of inherited neurometabolic diseases: the future.X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.Alkaptonuria: leading to the treasure in exceptions.The X-linked adrenoleukodystrophy (X-ALD) and oxidative stress.Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelinesNutritional therapy for selected inborn errors of metabolism.Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis.Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.Adrenomyeloneuropathy presenting in adulthood.Lorenzo's oil therapy of adrenoleukodystrophy.Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients.Adrenoleucodystrophy.Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders.Uptake and metabolism of plasma-derived erucic acid by rat brain.
P2860
Q24673003-C4E0DAE9-F0E9-414B-B797-AD6C0B2A5264Q26775566-D0A298A1-4C76-4C28-9E5C-3E19CD662703Q33497308-9E32A160-83FF-48CC-9538-BD01BC5BF752Q34075041-C04A6DA5-DACD-48BA-9824-D8AD3223F87FQ35585150-0446B762-FD20-4F53-83CC-5F1D736AC07AQ36119735-24425079-B135-4462-850F-5463AFBD890AQ36316914-24A609CB-E63E-4085-8C52-61410837EF1BQ36433474-92AD7879-569E-4C75-BF90-67CC441B2916Q36743396-5602EC2B-149F-45A1-B285-0AE4EEFFD21BQ37558494-1136621B-353A-4A06-A935-DB5BADB46F7BQ38712479-CE3C8469-C141-4623-A819-87F443ED02B5Q38859739-8B765AF6-2FC1-4473-B93C-964191203D7DQ38867787-1DF20BDE-8799-444F-A110-1690DF4BAA6FQ40302816-D9F8798F-3337-47A9-98C5-E5466383DB16Q40441784-DAAF3455-CA84-42F1-A61A-00979E054B5BQ42558095-07667F75-774C-4C8E-A1E0-797DAF584DF8Q42964131-0AA42737-B773-44AB-9320-D4A336E4FC29Q44603130-67F06EA4-8DAE-4485-8BD0-D719DF883AE6Q46981518-F6AA2F07-F8F2-48AA-876C-97A69F46AAA0
P2860
A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
A new dietary therapy for adre ...... inical results in 36 patients.
@en
A new dietary therapy for adre ...... inical results in 36 patients.
@nl
type
label
A new dietary therapy for adre ...... inical results in 36 patients.
@en
A new dietary therapy for adre ...... inical results in 36 patients.
@nl
prefLabel
A new dietary therapy for adre ...... inical results in 36 patients.
@en
A new dietary therapy for adre ...... inical results in 36 patients.
@nl
P2093
P2860
P356
P1433
P1476
A new dietary therapy for adre ...... inical results in 36 patients.
@en
P2093
Cornblath D
Sanders DB
P2860
P304
P356
10.1002/ANA.410210305
P577
1987-03-01T00:00:00Z